No connection

Search Results

ARLO Arlo Technologies, Inc. - Fundamental Analysis

NEUTRAL
Sign in to save Save to watchlist or track a position.
ARLO Stock | Fundamental Analysis & Investment Insights
NYSE Industrials Building Products & Equipment
Current Price Live
$12.99
Analyst Target
$23.2
+78.6% Upside
52W High
$19.94
52W Low
$7.84

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$1.38B
P/E
433.0
ROE
3.8%
Profit margin
0.8%
Debt/Equity
0.07
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
65%
ARLO exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to assess bankruptcy risk. While the company shows strong recent earnings growth and beats on earnings surprises, profitability remains thin with negative ROA and elevated valuation multiples. The stock trades significantly above its Graham Number of $0.91 and intrinsic value of $0.21, suggesting substantial premium pricing. Analysts maintain a strong_buy recommendation, but insider selling worth $17.9M over the past six months raises caution, offsetting bullish sentiment.

Key Strengths

Strong recent earnings performance with 4 out of the last 5 quarters beating estimates and high positive surprises
Low debt burden with a Debt/Equity ratio of just 0.07, indicating conservative capital structure
Improving earnings trend: YoY EPS growth of +45.5% and Q/Q EPS growth of +433.3%
Analyst consensus is strong_buy with a high target price of $23.20 implying 78% upside
Gross margin of 41.63% is healthy relative to sector despite low net profitability

Key Risks

Weak financial health: Piotroski F-Score of 4/9 suggests instability and lack of Altman Z-Score increases uncertainty
Extremely high P/E of 433.00 indicates potential overvaluation, especially compared to forward P/E of 16.56
Negative ROA of -0.41% signals inefficient asset utilization and poor profitability
Insiders have been aggressively selling, with $17.9M in sales and zero buys in the last 6 months
Price/Sales of 2.70 and Price/Book of 10.63 are elevated relative to minimal profit margins
AI Fair Value Estimate
Based on comprehensive analysis
$10.5
-19.2% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
41
Moderate
Value
35
Future
70
Past
60
Health
42
Dividend
0
AI Verdict
Cautiously optimistic with significant financial health and valuation concerns
Key drivers: High analyst target implies growth expectations, Recent earnings momentum, Low leverage, Overvalued metrics, Negative insider sentiment
Confidence
70%
Value
35/100

Ref P/E, PEG, Graham Number

Positives
  • Forward P/E of 16.56 is reasonable
Watchpoints
  • Current P/E of 433.00 is extremely high
  • Price/Book of 10.63 is elevated
  • Price/Sales of 2.70 not justified by current margins
  • Stock trades far above Graham Number ($0.91) and intrinsic value ($0.21)
Future
70/100

Ref Growth rates

Positives
  • Revenue growth of 1.40% is modest but positive
  • Strong YoY EPS growth of +45.5%
  • Q/Q EPS growth of +433.3% indicates sharp improvement
  • Analyst target suggests strong future upside
Watchpoints
  • Earnings growth data incomplete (N/A for some periods)
  • Revenue growth lags peer average of 17.89%
Past
60/100

Ref Historical trends

Positives
  • Consistent pattern of beating earnings estimates in recent quarters
  • Turnaround from large losses to profitability since 2022
Watchpoints
  • Historical losses in multiple prior quarters
  • Profitability only recently achieved
Health
42/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Current ratio of 1.42 and quick ratio of 1.14 indicate adequate short-term liquidity
  • Debt/Equity of 0.07 shows minimal leverage
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health
  • ROA of -0.41% is negative
  • No Altman Z-Score available for distress assessment
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • Dividend strength score of 0/100
  • Payout ratio is 0.00%

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$12.99
Analyst Target
$23.2
Upside/Downside
+78.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ARLO and closest competitors.

Updated 2026-01-23
Company 5Y 3Y 1Y 6M 1M 1W
ARLO
Arlo Technologies, Inc.
Primary
+60.2% +244.6% +8.2% -20.0% -7.4% -7.8%
BW
Babcock & Wilcox Enterprises, Inc.
Peer
+38.8% +93.9% +991.4% +278.1% +9.4% -19.8%
ALGT
Allegiant Travel Company
Peer
-71.1% -15.9% +40.3% +15.9% -31.4% -5.6%
ASTE
Astec Industries, Inc.
Peer
-8.6% +43.5% +75.4% +34.5% +30.3% +5.7%
AMPX
Amprius Technologies, Inc.
Peer
+11.7% +73.2% +231.4% +36.2% +30.9% +1.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
433.0
Forward P/E
16.56
PEG Ratio
N/A
P/B Ratio
10.63
P/S Ratio
2.7
EV/Revenue
2.39
EV/EBITDA
1000.12
Market Cap
$1.38B

Profitability

Profit margins and return metrics

Profit Margin 0.84%
Operating Margin 0.62%
Gross Margin 41.63%
ROE 3.8%
ROA -0.41%

Growth

Revenue and earnings growth rates

Revenue Growth +1.4%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.07
Low debt
Current Ratio
1.42
Good
Quick Ratio
1.14
Good
Cash/Share
$1.56

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-26
$N/A
2025-11-06
$0.16
+8.0% surprise
2025-08-07
$0.03
-14.3% surprise
2025-05-08
$0.15
+28.2% surprise

Industrials Sector Comparison

Comparing ARLO against 122 companies in the Industrials sector (6 bullish, 58 neutral, 58 bearish)
P/E Ratio
433.0
This Stock
vs
73.3
Sector Avg
+490.7% (Expensive)
Return on Equity (ROE)
3.8%
This Stock
vs
7.81%
Sector Avg
-51.3% (Below Avg)
Profit Margin
0.84%
This Stock
vs
58.28%
Sector Avg
-98.6% (Weaker)
Debt to Equity
0.07
This Stock
vs
5.47
Sector Avg
-98.7% (Less Debt)
Revenue Growth
1.4%
This Stock
vs
21.59%
Sector Avg
-93.5% (Slower)
Current Ratio
1.42
This Stock
vs
2.66
Sector Avg
-46.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
ARLO
Arlo Technologies, Inc.
NEUTRAL $1.38B 433.0 3.8% 0.8% $12.99
BW
Babcock & Wilcox Enterprises, Inc.
BEARISH $1.37B - -% -6.2% $10.51
ALGT
Allegiant Travel Company
BEARISH $1.38B - -4.2% -1.7% $75.04
ASTE
Astec Industries, Inc.
BULLISH $1.42B 29.71 5.9% 2.8% $62.09
AMPX
Amprius Technologies, Inc.
BEARISH $1.46B - -39.0% -53.2% $11.17

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2026-01-09 BINDER KURTIS JOSEPH Chief Financial Officer Sale 55,043 $753,500
2026-01-09 BUSSE BRIAN C General Counsel Sale 18,841 $257,920
2026-01-09 MCRAE MATTHEW BLAKE Chief Executive Officer Sale 90,089 $1,233,255
2026-01-08 MCRAE MATTHEW BLAKE Chief Executive Officer Stock Award 166,666 -
2026-01-08 BINDER KURTIS JOSEPH Chief Financial Officer Stock Award 100,000 -
2026-01-08 BUSSE BRIAN C General Counsel Stock Award 50,000 -
2025-12-01 MCRAE MATTHEW BLAKE Chief Executive Officer Sale 257,242 $3,672,876
2025-11-28 MCRAE MATTHEW BLAKE Chief Executive Officer Gift 563,293 -
2025-11-14 BUSSE BRIAN C General Counsel Sale 149,521 $2,149,140
2025-11-04 MCRAE MATTHEW BLAKE Chief Executive Officer Sale 18,645 $333,089
2025-11-03 MCRAE MATTHEW BLAKE Chief Executive Officer Stock Award 33,175 -
2025-10-15 BINDER KURTIS JOSEPH Chief Financial Officer Sale 51,668 $920,527
2025-10-02 BUSSE BRIAN C General Counsel Sale 9,171 $155,835
2025-10-02 MCRAE MATTHEW BLAKE Chief Executive Officer Sale 95,430 $1,621,566
2025-10-01 MCRAE MATTHEW BLAKE Chief Executive Officer Stock Award 178,094 -
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
5 analysts
BWS Financial
2025-11-11
Maintains
Buy Buy
BWS Financial
2025-08-11
Maintains
Buy Buy
Raymond James
2025-08-08
Maintains
Outperform Outperform

Past News Coverage

Recent headlines mentioning ARLO from our newsroom.

Newest → oldest
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile